{
    "body": "Treatment of which disease was investigated in the MR CLEAN study?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/25517348", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25432979", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25179366", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24330796"
    ], 
    "ideal_answer": [
        "Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN) study investigated endovascular treatment for acute ischemic stroke."
    ], 
    "exact_answer": [
        "acute ischemic stroke"
    ], 
    "type": "factoid", 
    "id": "54cf7051f693c3b16b000013", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 303, 
            "text": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS). ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25432979", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 302, 
            "text": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25432979", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1845, 
            "offsetInEndSection": 2223, 
            "text": "CONCLUSIONS: In patients with acute ischemic stroke caused by a proximal intracranial occlusion of the anterior circulation, intraarterial treatment administered within 6 hours after stroke onset was effective and safe. (Funded by the Dutch Heart Foundation and others; MR CLEAN Netherlands Trial Registry number, NTR1804, and Current Controlled Trials number, ISRCTN10888758.).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25517348", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 171, 
            "text": "MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25179366", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 480, 
            "offsetInEndSection": 744, 
            "text": " In our view, a rational and ethical approach would now be to treat quickly with IV rtPA and when possible, refer and include in new randomized clinical trials that compare intra-arterial treatment with standard care, such as MR CLEAN or BASICS in the Netherlands.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24330796", 
            "endSection": "abstract"
        }
    ]
}